Isolation and Characterization of a Monoclonal Antibody Specific for Epithelial Cells

Total Page:16

File Type:pdf, Size:1020Kb

Isolation and Characterization of a Monoclonal Antibody Specific for Epithelial Cells ICANCER RESEARCH 45. 783-790. February 1985| Isolation and Characterization of a Monoclonal Antibody Specific for Epithelial Cells Anne W. Hamburger,1 Yvonne A. Reid, Barbara Pelle, George E. Milo,2 Inge Noyes, Henry Krakauer, and J. Peter Fuhrer Cell Culture Department, American Type Culture Co/lection, Rockville, Maryland [A. W. H., Y. A. Ft., B. P./,' Comprehensive Cancer Center. Ohio State University, Columbus, Ohio [G. E. M., I. N.¡;and the National Institute of Allergy and Infectious Diseases [H. K.¡and the National Cancer Institute, Bethesda. Maryland [J. P. F.] ABSTRACT monoclonal antibodies have been isolated (9, 15, 19, 29), rela tively few monoclonal antibodies specific for epidermal cell sur Monoclonal antibodies were generated to antigens on human face antigens have been described (18). foreskin keratinocytes to identify epithelial-specific molecules. Cell cultures of human epidermis retain epidermal-specific Spleen cells from BALB/c mice, immunized with membrane functions and antigens (10, 11, 20). Thus, these keratinocyte preparations from primary expiants of foreskin epithelial cells, cultures could serve as immunogens in attempts to produce were fused with the NS-1 mouse myeloma line. Hybridoma monoclonal antibodies specific for keratinocyte cell surface an supernatants were screened for the desired immunological reac tigens. We now describe the isolation of hybridomas secreting tivity using enzyme-linked immunosorbant binding assays. Hy- monoclonal antibodies which bind selectively to cultured normal bridomas secreting antibodies reacting with epithelial cells, but keratinocytes and show a high specificity for both cultured and not fibroblasts or lymphocytes, were cloned by limiting dilution, primary epithelial tissues. and two stable clones producing immunoglobulin M K antibodies were selected for study. Evaluation of fixed paraffin-embedded human tissue by an indirect immunoperoxidase technique re MATERIALS AND METHODS vealed that the antibodies bound most strongly to normal strati fied squamous and transitional epithelium, and squamous and Cells and Media. The following human cell lines were obtained from transitional cell carcinomas. Antibodies from the cloned hybri- the American Type Culture Collection, Rockville, MD: B-lymphoblastoid domas also reacted with primary cell cultures of foreskin keratin lines: CCL 213 (Daudi), CCL 114 (RPMI 766); T-lymphoblastoid lines: CCL 119 (CCRF-CEM), CRL 1552 (Molt-3); melanoma: CRL 1424 (G- ocytes, pulmonary epithelium, fetal liver, and amnion cells, but 361), HTB 64 (Malme-64); neuroblastoma: CCL 127 (IMR 32), HTB 11 not with primary cultures of nonepithelial cells. Further testing (SK-N-SH); adrenal adenocarcinoma: CCL 105 (SW 13); carcinoma of by enzyme-linked immunosorbent assays revealed that the an tibodies reacted with some long-term cell lines derived from the pharynx: CCL 138 (Detroit 562); adenocarcinoma of the colon: CCL 220 (Colo 320 DM), CCL 218 (WiDr); adenocarcinoma of the prostate: epithelial tumors. Nonepithelial cell lines were not stained by the HTB 81 (DU 145), CRL 1425 (PC-3); carcinoma of the lung: CCL 185 antibodies. Indirect immunofluorescent studies indicated that (A549, epidermoid carcinoma), HTB 54 (CALU-1, adenocarcinoma); tran staining was confined to the cell surface. These antibodies may sitional cell carcinoma of the bladder: CRL 1473 (HT-1197), HTB-2 (RT- prove useful in studies of differentiation markers of human epi 4); squamous cell carcinoma: CRL 1623 (SCC-15); carcinoma of the thelial cells. pancreas: CRL 1420 (MIA-PaCa-2), CRL 1469 (PANC-1, ductal carci noma); carcinoma of the cervix: CCL 2 (HeLa); renal leiomyoblastoma: CRL 1440 (G-402); Wilms1 tumor: CRL 1441 (G-401); choriocarcinoma: INTRODUCTION CCL 98 (BeWO); adenocarcinoma of the breast: CRL 1500 (ZR 75-1), CRL 1504 (ZR-75-30); foreskin fibroblasts: CRL 1521 (CCD-76), CCL Specific molecular markers which identify cell types in epithelial 109 (Detroit 550); fibrosarcoma: CCL 121 (HT-1080); and Ewing's sar tissue are important for the characterization of cells grown in coma HTB 87 (SK-ES-1 ). A primate cell line from African green monkey culture and for studies of phenotypic changes in carcinogenesis, kidney cells, CCL 70 (CV 1), was also used. The human melanoma cell and they may have applications in clinical diagnosis and organ line WM-9 and a line of normal human lung fibroblasts were obtained transplantation. from the Wistar Institute. A line of epithelial cells derived from normal BALB/c mouse skin (BK-1 ) was obtained from Dr. Stuart Yuspa, National Several proteins have been identified as markers of epithelial Cancer Institute. Primary cultures of human foreskin epithelial cells, lung tissue. Autoantibodies in the serum of patients with bullous fibroblasts, pulmonary epithelia, and epithelial cells from fetal liver were pemphigus and pemphigus vulgaris have been used to detect prepared in the laboratory of Dr. George Milo. Undifferentiated prolifer epidermal-associated antigens and to study epidermal differen ating keratinocytes were prepared as follows (22). Foreskin tissue was tiation (25). Epidermal-specific histocompatibility antigens, be cut into 4-mm pieces in 4 ml of HBSS3 minus calcium and magnesium lieved responsible for immunogenicity of skin allografts, include at pH 7.2 at 21°. Tissue pieces were rinsed 3 times, recovered, and the SKA antigens in mice (3) and a non-H-2 alloantigen (epa) placed in 3 ml of prechilled HBSS solution containing 0.125% trypsin identified on murine epidermal cells (26). Keratin, a major differ (Worthington Enzymes, Freehold, NY) and 0.02% EGTA. After 24 hr, the entiation product of epidermal cells, is also considered to be an tissue was removed, and the upper epidermal layers were mechanically epithelial-specific marker (7, 27). While several keratin-specific separated from the dermal tissue and the attached stratum basalis. The lower layer containing the dermis and stratum basalis was placed in 3 1Recipient of support in part from Contract NO102655 from the National Institute ml of HBSS minus calcium and magnesium containing 0.2% trypsin and of Allergy and Infectious Diseases. To whom requests for reprints should be 3 The abbreviations used are: HBSS. Hanks' balanced salt solution; FBS, fetal addressed 2 Recipient of support from Grant NCI RO1CA 25907-04. bovine serum; EGTA, etnyleneglycol bis(/i-aminoethylether)-N,/V,N',W '-tetraacetic Received May 5. 1983: accepted November 5. 1984. acid; ELISA, enzyme-linked immunosorbent assay. CANCER RESEARCH VOL. 45 FEBRUARY 1985 783 Downloaded from cancerres.aacrjournals.org on September 30, 2021. © 1985 American Association for Cancer Research. EPITHELIAL-SPECIFIC MONOCLONAL ANTIBODIES 0.02% EGTA, pH 3.9 to 4.2.' The tissue suspension was reincubated at diaminobenzidine and 0.03% hydrogen peroxide. Sections were coun- 8°for an additional 24 hr. The dermal pieces free of the stratum basalis terstained in hematoxylin:eosin. Cytocentrifuge preparations of single- were removed. Freely floating cells from the stratum basalis were re cell suspensions of human tissue or cell lines were fixed in absolute covered by centrifugation at 650 x g. These cells were seeded at 5000 methanol and stained in the same manner. cells/25-sq cm flask in Eagle's minimal essential medium supplemented Immunofluorescence Studies. Indirect immunofluorescence studies with 10% FBS and 0.75 rriM calcium (total free calcium). using monoclonal antibodies were performed on cells growing on glass Keratinocytes were serially passaged by treatment of confluent mon- coverslips or on 5-/¿mcryostat sections of human tissue. Cells were olayers with 0.25% trypsin in HBSS:0.02% EDTA at pH 7.2. The cells initially fixed in -20° methanol and acetone as described by Sun ef al. were seeded in Eagle's minimal essential medium supplemented with (27) and stained with the appropriate monoclonal antibody and then 10% FBS and 0.75 ÕTIMcalciumat 106 cells/25 sq cm (1:2). The cells at fluorescein-conjugated goat anti-mouse IgM (Cappel Laboratories, Coch- primary passage exhibited a 75 to 90% attachment efficiency. ranville, PA). Cells were also stained with a monoclonal antibody to All tumor cell lines were grown in monolayer culture as described (2). intermediate filaments (TIB 131) obtained from the American Type Cul The lymphoblastoid lines were grown in RPMI 1640 with 20% FBS. ture Collection or a rabbit anti-human keratin heteroantibody that was Purified human peripheral blood mononuclear cells and bone marrow the generous gift of Dr. T. T. Sun, New York University. In later experi cells were separated by buoyant density centrifugation on Ficoll:Hypaque ments, cells were stained with both antibodies and then fixed in 95% by standard techniques. ethanol:5% glacial acetic acid and mounted in Gelvatol as described (24). The NS-1 cell line (obtained from Mark Lostrum, Fred Hutchinson The cells were viewed using a Zeiss epiilluminated fluorescent micro Cancer Center, Seattle, WA) was grown as a stationary suspension scope. culture in RPMI 1640 with 20% FBS and treated with 10~8 M 8-azagua- Analysis of Monoclonal Antibodies. Antibodies were tested for class nine 3 weeks prior to its use in fusions. Hybridoma cell lines were and subclass by Ouchterlony immunodiffusion using antisera specific for maintained as described for NS-1 cells. the major mouse immunoglobulin classes and for the subclasses of IgG Generation of Hybridoma Cell Lines. BALB/c mice were immunized and light chains. Immunoglobulin class was confirmed by sodium dodecyl by 2 i.p. injections (administered 15 weeks apart) of 100 ^g of membrane- sulfate gel electrophoresis of metabolically labeled antibodies as de enriched preparations (4) of primary cultures of human keratinocytes in scribed (13,16, 23). complete Freund's adjuvant. The third, and final, injection of 100 ßQof membrane protein in phosphate-buffered saline was administered i.v. 3 weeks after the second injection. Three days after the final injection, the RESULTS spleens were excised, and spleen cells were fused with NS-1 cells in the presence of 40% Polyethylene Glycol 4000 as described previously (5). Generation of Monoclonal Antibodies.
Recommended publications
  • CCR7 Antibody (Y59) NB110-55680
    Product Datasheet CCR7 Antibody (Y59) NB110-55680 Unit Size: 0.1 ml Store at -20C. Avoid freeze-thaw cycles. Publications: 9 Protocols, Publications, Related Products, Reviews, Research Tools and Images at: www.novusbio.com/NB110-55680 Updated 5/28/2019 v.20.1 Earn rewards for product reviews and publications. Submit a publication at www.novusbio.com/publications Submit a review at www.novusbio.com/reviews/destination/NB110-55680 Page 1 of 6 v.20.1 Updated 5/28/2019 NB110-55680 CCR7 Antibody (Y59) Product Information Unit Size 0.1 ml Concentration This product is unpurified. The exact concentration of antibody is not quantifiable. Storage Store at -20C. Avoid freeze-thaw cycles. Clonality Monoclonal Clone Y59 Preservative 0.01% Sodium Azide Isotype IgG Purity Tissue culture supernatant Buffer 49% PBS, 0.05% BSA and 50% Glycerol Target Molecular Weight 45 kDa Product Description Host Rabbit Gene ID 1236 Gene Symbol CCR7 Species Human, Mouse, Rat, Monkey Reactivity Notes May cross reacts with Rhesus monkey. Specificity/Sensitivity The antibody does not cross-react with other G-protein coupled receptor 1 family members. Immunogen A synthetic peptide corresponding to residues in N-terminal extracellular domain of human CKR7 was used as immunogen. Notes Produced using Abcam's RabMab® technology. RabMab® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487. Product Application Details Applications Western Blot, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Immunohistochemistry-Frozen, Immunohistochemistry- Paraffin, Immunoprecipitation, Flow Cytometry (Negative) Recommended Dilutions Western Blot 1:1000-10000, Immunohistochemistry 1:10-1:500, Immunocytochemistry/Immunofluorescence 1:250, Immunoprecipitation 1:10, Immunohistochemistry-Paraffin 1:250, Immunohistochemistry-Frozen 1:250, Flow Cytometry (Negative) Application Notes This product is useful for: Western Blot, Immunohistochemistry-Paraffin, Immunocytochemistry, Immunoprecipitation.
    [Show full text]
  • Memoranaurns by the Participants in Signes Par Les Partici- I the Meeting
    Memoranda are state- Les Memorandums ments concerning the exposent les conclu- /e , conclusions or recom- sions et recomman- M e mmooranrantedaa mendations of certain dations de certaines / a t w / /WHO scientific meet- /reunions scientifiques ings; they are signed de /'OMS; ils sont Memoranaurns by the participants in signes par les partici- I the meeting. pants a ces reunions. Bulletin ofthe World Health Organization, 62 (2): 217-227 (1984) © World Health Organization 1984 Immunodiagnosis simplified: Memorandum from a WHO Meeting* Technologies suitable for the development ofsimplified immunodiagnostic tests were reviewed by a Working Group of the WHO Advisory Committee on Medical Research in Geneva in June 1983. They included agglutination tests and use ofartificialparticles coated with immunoglobulins, direct visual detection of antigen-antibody reactions, enzyme- immunoassays, and immunofluorescence and fluoroimmunoassays. The use of mono- clonal antibodies,in immunodiagnosis and of DNA /RNA probes to identify viruses was also discussed in detail. The needfor applicability of these tests at three levels, i.e., field conditions (or primary health care level), local laboratories, and central laboratories, was discussed and their use at thefield level was emphasized. Classical serological techniques have been used for All these tests can be carried out in laboratories that a long time for diagnostic purposes, e.g., for con- are equipped with basic instruments as well as special- firmation of clinical diagnoses, epidemiological ized apparatus (e.g., gamma counters for RIA, ultra- studies, testing of blood donors, etc. Some of these violet microscopes for IMF, etc.), which are usually techniques have been standardized to a high degree of available only in the larger, central laboratories.
    [Show full text]
  • Cytokine Immunocytochemistry Fax (65) 860-1590 Fax (49) 40 531 58 92 Fax (81) 3 541-381-55 E-Mail: [email protected]
    PharMingen International United States Canada PharMingen Europe Japan PharMingen Canada Tel 619-812-8800 Asia Pacific Becton Dickinson GmbH Nippon Becton Dickinson Toll-Free 1-888-259-0187 Orders 1-800-848-6227 BD Singapore HQ PharMingen Europe Company Ltd. Tel 905-542-8028 Tech Service 1-800-825-5832 Tel (65) 860-1478 Tel (49) 40 532 84 48 0 Tel (81) 3 541-382-51 Fax 905-542-9391 Fax 619-812-8888 Cytokine Immunocytochemistry Fax (65) 860-1590 Fax (49) 40 531 58 92 Fax (81) 3 541-381-55 e-mail: [email protected] http://www.pharmingen.com Africa Germany Latin/South America Spain Becton Dickinson Worldwide Inc. Becton Dickinson GmbH BDIS (USA) Becton Dickinson S.A. Reagents and Techniques Tel (254) 2 449 608 HQ PharMingen Europe Tel (408) 954-2157 Tel (34) 91 848 8100 Fax (254) 2 449 619 Tel (49) 40 532 84 48 0 Fax (408) 526-1804 Fax (34) 91 848 8105 Fax (49) 40 531 58 92 Orders for Microscopic Analysis of Cytokine-Producing Cells Australia Malaysia Tel (34) 91 848 8182 Becton Dickinson Pty Ltd Greece Becton Dickinson Sdn Bhd Fax (34) 91 848 8104 Tel (612) 9978-6800 Becton Dickinson Hellas S.A. Tel (03) 7571323 Fax (612) 9978-6850 Tel (30) 1 9407741 Fax (03) 7571153 Sweden Fax (30) 1 9407740 Becton Dickinson AB Austria Mexico Tel (46) 8 775 51 00 Becton Dickinson GmbH Hong Kong Becton Dickinson de Mexico Fax (46) 8 645 08 08 HQ PharMingen Europe Becton Dickinson Asia Ltd Tel (52-5) 237-12-98 Tel (49) 40 532 84 48 0 Tel (852) 2572-8668 Fax (52-5) 237-12-93 Switzerland Fax (49) 40 531 58 92 Fax (852) 2520-1837 Becton Dickinson GmbH Middle East HQ PharMingen Europe Belgium Hungary Becton Dickinson Tel (41) 06 1-385 4422 Becton Dickinson Benelux N.V.
    [Show full text]
  • Diagnostic Potential of the Haemagglutination
    Bulgarian Journal of Veterinary Medicine (2007), 10 , N o 3, 169 −178 DIAGNOSTIC POTENTIAL OF THE HAEMAGGLUTINATION INHIBITION TEST, THE IMMUNODIFFUSION TEST AND ELISA FOR DETECTION OF ANTIBODIES IN CHICKENS, INTRAVENOUSLY INFECTED WITH A/DUCK/BULGARIA/05 H6N2 AVIAN INFLUENZA VIRUS ISOLATE I. S. ZARKOV Faculty of Veterinary Medicine, Trakia University, Stara Zagora, Bulgaria Summary Zarkov, I., 2007. Diagnostic potential of the haemagglutination inhibition test, the immuno- diffusion test and ELISA for detection of antibodies in chickens, intravenously infected with A/duck/Bulgaria/05 H6N2 avian influenza virus isolate. Bulg. J. Vet. Med. , 10 , No 3, 169 −178. After experimental infection of chickens with an avian influenza viral isolate A/duck/Bulgaria/05 H6N2, the potential of the haemagglutination inhibition test (HIT), the immunodiffusion test (IDT) and enzyme-linked immunosorbent assay (ELISA) for antibody detection was evaluated. The results evidenced that in birds, haemagglutinins, precipitins and IgG antibodies, detectable with ELISA, were formed. The percentage of chickens with subtype-specific antibodies was the highest by the 21 st day of infection (100 %), followed by the 14 th (66.7 %) and the 28 th (55.6 %) days, and was the lowest by the 7 th day (44.4 %). Serum titres ranged between 1:4 and 1:256 with predomination of 1:8 and 1:16 titres (29.2 % each). The mean arithmetic titre for the experiment was 1:38.2. The highest percentage of chickens with precipitins was observed by the 14th day (55.6 %) followed by the 7 th , 21 st and the 28 th days with 33.3 % each.
    [Show full text]
  • AG 39: Immunofluorescence Assays (PDF)
    ibidi Application Guide Immunofluorescence Assays The Principle of Immunofluorescence Immunofluorescence Applied: Assays . 2 Experimental Examples . 13 Rat Hippocampal Neuron and Astrocyte Staining 14 Immunofluorescence Staining: Visualization of Endothelial Cell Junctions . 13 A Typical Workflow . 3 Immunostaining of Rat Dorsal Root Ganglionic Experiment Planning and Sample Preparation . 4 Cells and Schwann Cells . 13 Sample Fixation . 4 Adherens Junctions and Actin Cytoskeleton of Cell Permeabilization . 5 HUVECs Under Flow . 14 Blocking . 5 Mitochondria Staining of MDCK cells . 14 Primary Antibody Incubation . 5 Focal Adhesions of Differentiated Mouse Fibroblasts on an Elastic Surface . 15 Secondary Antibody Incubation . 6 Counterstain and Mounting . 7 Microscopy . 7 Troubleshooting . 8 Selected Publications Immunofluorescence C. Xu, et al. NPTX2 promotes colorectal cancer growth and liver With the ibidi Chambers . 9 metastasis by the activation of the canonical Wnt/beta-catenin pathway via FZD6. Cell Death & Disease, 2019, 10.1038/s41419- Comparison of Immunocytochemistry Protocols . 10 019-1467-7 Chambered Coverslips . 11 read abstract Kobayashi, T., et al. Principles of early human development and Channel Slides . 11 germ cell program from conserved model systems. Nature, Chamber Slides . 12 2017, 10.1038/nature22812 read abstract H. Tada et al. Porphyromonas gingivalis Gingipain-Dependently Enhances IL-33 Production in Human Gingival Epithelial Cells. PloS one, 2016, 10.1371/journal.pone.0152794 read abstract N. J. Foy, M. Akhrymuk, A. V. Shustov, E. I. Frolova and I. Frolov. Hypervariable Domain of Nonstructural Protein nsP3 of Venezuelan Equine Encephalitis Virus Determines Cell-Specific Mode of Virus Replication. Journal of Virology, 2013, 10.1128/ jvi.00720-13 read abstract .com The Principle of Immunofluorescence Assays Immunofluorescence (IF) is a powerful approach for getting insight into cellular structures and processes using microscopy .
    [Show full text]
  • Serological Methods in the Identification and Characterization of Viruses
    CHAPTER 4 Serological Methods in the Identification and Characterization of Viruses M. H. V. Van Regenmortel Laboratoire de Virologie Institut de Biologie Mo!eculaire et Cellulaire 67000 Strasbourg, France 1. INTRODUCTION The purpose of this chapter is to present an integrated view of the various serological techniques that have been used in virology. The accent will be placed on the principles that govern each type of test and on the general applicability of the different serological techniques in all fields of virus research. In recent years, advances in serological tech­ niques have sometimes been applied in only one area of virology, although they could have been equally useful to workers studying other groups of viruses. No doubt this stems from the host-oriented approach that has guided the compartmentation of virology into separate fields of specialization. When it comes to serological properties, however, the similarities between animal, insect, bacterial, and plant viruses are paramount. The same immunochemical principles govern the in vitro serological reactions of all viral antigens, and much of general interest can be learned from the findings obtained with each particular group of viruses. An attempt will be made here to emphasize the general validity of specific experimental procedures. A number of recent reviews restricted to the serology of particular groups of viruses are available 183 H. Fraenkel-Conrat et al. (eds.), Comprehensive Virology © Plenum Press, New York 1981 184 Chapter 4 (Cowan, 1973; Schmidt and Lennette, 1973; Ball, 1974; Kurstak and Morisset, 1974; Burns and Allison, 1975; Mazzone and Tignor, 1976; Mayr et al., 1977; Tyrrell, 1978; Van Regenmortel, 1978; Cooper, 1979).
    [Show full text]
  • 116588NCJRS.Pdf
    If you have issues viewing or accessing this file contact us at NCJRS.gov. " "'- u.s. Department of Justice Federal Bureau of Investigation PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ON FORENSIC IMMUNOLOGY FBI ACADEMY QUANTICO, VIRGINIA JUNE 23-26, 1986 Proceedings of the International Symposium on Forensic Immunology co 00 L() \0 u, r-l O§ r-l Ql C. If) 05~ Ql 0- 0 ~ o~ Ql E C/) Ql >. c:0 If) C/) ~ * ....,a: () a: z Ql '*02 Ql iii :5 ...... ....,::> a Ql {ij "...:0- Ql c: !!lc: °E ::>;: B 00 {ij c: 0 ~I::> z~ "e CD ~~ :5 .... ~o- S 1::C: Lt .~ Host Laboratory Division Federal Bureau of Investigation June 23-26, 1986 Forensic Science Research and Training Center FBI Academy Quantico, Virginia NOTICE This publication was prepared by the U. S. Government. Neither the U. S. Government nor the U. S. Department of Justice nor any of their employees makes any warranty, express or implied, or assumes any legal liability or responsibility for the accuracy, completeness or usefulness of any information, apparatus, product or process disclosed, or represents that in use would not infringe privately owned rights. Reference herein to any specific commercial product, process or service by trade name, mark, manufacturer or otherwise does not necessarily constitute or imply its endorsement, recommendation or favoring by the U. S. Government or any agency thereof. The views and opinions of authors expressed herein do not necessarily state or reflect those of the U. S. Government or any agency thereof. Published by: The Laboratory Division Roger T. Castonguay Assistant Director in Charge Federal Bureau of Investigation U.
    [Show full text]
  • Laboratory Analysis of the Immune Response 859
    Chapter 20 | Laboratory Analysis of the Immune Response 859 Chapter 20 Laboratory Analysis of the Immune Response Figure 20.1 Lab-on-a-chip technology allows immunological assays to be miniaturized so tests can be done rapidly with minimum quantities of expensive reagents. The chips contain tiny flow tubes to allow movement of fluids by capillary action, reactions sites with embedded reagents, and data output through electronic sensors. (credit: modification of work by Maggie Bartlett, NHGRI) Chapter Outline 20.1 Polyclonal and Monoclonal Antibody Production 20.2 Detecting Antigen-Antibody Complexes 20.3 Agglutination Assays 20.4 EIAs and ELISAs 20.5 Fluorescent Antibody Techniques Introduction Many laboratory tests are designed to confirm a presumptive diagnosis by detecting antibodies specific to a suspected pathogen. Unfortunately, many such tests are time-consuming and expensive. That is now changing, however, with the development of new, miniaturized technologies that are fast and inexpensive. For example, researchers at Columbia University are developing a “lab-on-a-chip” technology that will test a single drop of blood for 15 different infectious diseases, including HIV and syphilis, in a matter of minutes.[1] The blood is pulled through tiny capillaries into reaction chambers where the patient’s antibodies mix with reagents. A chip reader that attaches to a cell phone analyzes the results and sends them to the patient’s healthcare provider. Currently the device is being field tested in Rwanda to check pregnant women for chronic diseases. Researchers estimate that the chip readers will sell for about $100 and individual chips for $1.[2] 1.
    [Show full text]
  • Virology Techniques
    Chapter 5 - Lesson 4 Virology Techniques Introduction Virology is a field within microbiology that encom- passes the study of viruses and the diseases they cause. In the laboratory, viruses have served as useful tools to better understand cellular mechanisms. The purpose of this lesson is to provide a general overview of laboratory techniques used in the identification and study of viruses. A Brief History In the late 19th century the independent work of Dimitri Ivanofsky and Martinus Beijerinck marked the begin- This electron micrograph depicts an influenza virus ning of the field of virology. They showed that the agent particle or virion. CDC. responsible for causing a serious disease in tobacco plants, tobacco mosaic virus, was able to pass through filters known to retain bacteria and the filtrate was able to cause disease in new plants. In 1898, Friedrich Loef- fler and Paul Frosch applied the filtration criteria to a disease in cattle known as foot and mouth disease. The filtration criteria remained the standard method used to classify an agent as a virus for nearly 40 years until chemical and physical studies revealed the structural basis of viruses. These attributes have become the ba- sis of many techniques used in the field today. Background All organisms are affected by viruses because viruses are capable of infecting and causing disease in all liv- ing species. Viruses affect plants, humans, and ani- mals as well as bacteria. A virus that infects bacteria is known as a bacteriophage and is considered the Bacteriophage. CDC. Chapter 5 - Human Health: Real Life Example (Influenza) 1 most abundant biological entity on the planet.
    [Show full text]
  • Immunocytochemistry of Cytology Specimens for Predictive Biomarkers in Lung Cancer
    905 Review Article on Selected Highlights of the 2019 Pulmonary Pathology Society Biennial Meeting Immunocytochemistry of cytology specimens for predictive biomarkers in lung cancer Sinchita Roy-Chowdhuri Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Correspondence to: Sinchita Roy-Chowdhuri, MD, PhD. Department of Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd. Unit 85, Houston, TX 77030, USA. Email: [email protected]. Abstract: With a growing number of predictive biomarkers that have emerged in non-small cell lung carcinoma (NSCLC), there has been a paradigm shift in the management of these patients. Of the various predictive biomarker testing methods, immunohistochemistry (IHC) is the most widely available, cost- effective, and commonly used methods. However, most predictive IHC assays are validated primarily on formalin-fixed paraffin-embedded (FFPE) histologic tissue samples and translating these assays to cytologic specimens requires additional and rigorous validation. This is part due to the lack of standardized processing protocols in cytology resulting in a variety of preanalytic variables that can impact the antigenicity of antibodies used for predictive biomarker testing. The review article discusses the various preanalytical and analytical factors that impact immunocytochemistry (ICC) in cytologic specimens and summarizes the current published literature on ALK, ROS1, PD-L1, and other predictive biomarker ICC in cytology. Keywords: Immunocytochemistry (ICC); lung cancer; cytology; biomarkers; non-small cell lung carcinoma (NSCLC) Submitted Dec 14, 2019. Accepted for publication Dec 25, 2019. doi: 10.21037/tlcr.2019.12.31 View this article at: http://dx.doi.org/10.21037/tlcr.2019.12.31 Predictive biomarkers are markers of therapeutic efficacy, embedded (FFPE) histologic tissue samples, a large fraction the results of which are essential for determining patient of NSCLC patients are diagnosed on cytology samples, care.
    [Show full text]
  • EUROPEAN PHARMACOPOEIA Free Access to Supportive Pharmacopoeial Texts in the Field of Vaccines for Human Use During the Coronavirus Disease (COVID-19) Pandemic
    EUROPEAN PHARMACOPOEIA Free access to supportive pharmacopoeial texts in the field of vaccines for human use during the coronavirus disease (COVID-19) pandemic Updated package - October 2020 Published in accordance with the Convention on the Elaboration of a European Pharmacopoeia (European Treaty Series No. 50) European Directorate Direction européenne for the Quality de la qualité of Medicines du médicament & HealthCare & soins de santé Council of Europe Strasbourg Free access to supportive pharmacopoeial texts in the field of vaccines for human use during the coronavirus disease (COVID-19) pandemic Updated package The EDQM is committed to supporting users during the coronavirus disease (COVID-19) pandemic – as well as contributing to the wider global effort to combat the virus – by openly sharing knowledge and providing access to relevant guidance/standards. To support organisations involved in the development, manufacture or testing of COVID-19 vaccines worldwide, many of which are universities and small and medium-sized enterprises, the EDQM is offeringte mporary free access to texts of the European Pharmacopoeia (Ph. Eur.) in the field of vaccines. This package includes quality standards for vaccines which developers can take into account to help build appropriate analytical control strategies for their COVID-19 candidate vaccines and ensure the quality and safety of the final product. Application of such quality requirements may ultimately help to facilitate regulatory acceptance of a subsequent marketing authorisation application. For ease of reading, a summary table listing the pharmacopoeial texts, with information regarding the vaccine types or vaccine platforms concerned (e.g. live attenuated viral vaccine, recombinant viral-vectored vaccines) is provided.
    [Show full text]
  • Interpretation of Serologic Tests
    COCCIDIOIDOMYCOSIS SEROLOGY LABORATORY School of Medicine, University of California, Davis, California, 95616-8645 George Thompson M.D., Director NPI: 1831206812 VETERINARY CLIENTS Application and Interpretation of Serologic Tests A. Our usual serologic tests for coccidioidomycosis are the following: 1. Qualitative: Immunodiffusion (ID) to determine presence of coccidioidal IgM ("precipitin") (test may be termed “IDTP”), or IgG (CF) (test may be termed “IDCF”) antibody in body fluids. This is appropriate if no diagnosis of coccidioidomycosis has previously been established. [Non-specific reactions resembling that given by the coccidioidal precipitin (IgM) are encountered infrequently with some sera, e.g. from patients who do not have coccidioidomycosis.] 2. Quantitative: For veterinary specimens, we estimate the titer of the CF (IgG) by quantitative immunodiffusion rather than by complement fixation (CF). This provides an approximation of the CF titer. The quantitative immunodiffusion rather than the CF test avoids the problem of anticomplementary activity frequently encountered especially with canine sera. Determination of titer is appropriate after a diagnosis has been established, e.g. by positive immunodiffusion or recovery of C. immitis from the patient. B. Results and interpretation: 1. Detection of coccidioidal antibody in a single specimen can be diagnostically significant; testing sequential samples can be helpful in following the course of the disease. 2. Immunodiffusion (ID) (qualitative) - presence or not of precipitin (IgM) or CF (IgG) antibody. The IgM is important in the diagnosis of acute primary coccidioidomycosis, and is detectable in most patients in 1 to 2 weeks after onset of symptoms, may persist several months, occasionally longer in association with a pulmonary cavity or disseminated disease.
    [Show full text]